TalpheraTLPH
TLPH
About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Employees: 15
0
Funds holding %
of 6,740 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
24% more capital invested
Capital invested by funds: $4.57M [Q1] → $5.64M (+$1.08M) [Q2]
11.19% more ownership
Funds ownership: 26.13% [Q1] → 37.32% (+11.19%) [Q2]
6% less funds holding
Funds holding: 31 [Q1] → 29 (-2) [Q2]
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$6
494%
upside
Avg. target
$6
494%
upside
High target
$6
494%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Ed Arce 56% 1-year accuracy 61 / 109 met price target | 494%upside $6 | Buy Reiterated | 16 Aug 2024 |
Financial journalist opinion
Charts implemented using Lightweight Charts™